Kumarasamy, Vishnu
Nambiar, Ram
Wang, Jianxin
Rosenheck, Hanna
Witkiewicz, Agnieszka K.
Knudsen, Erik S. http://orcid.org/0000-0002-5130-5969
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA247362, CA247362)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 14 September 2021
Revised: 11 May 2022
Accepted: 24 May 2022
First Online: 9 June 2022
Competing interests
: ESK and AKW have received research funding from Eli Lilly, Novartis and Pfizer over the last 5 years. There is no current research support from these entities and the study was written in the absence of input from any pharmaceutical company.